Cogent Biosciences, Inc. (COGT) Financials

COGT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 313.4 million 55.6 million
2023-09-30 355.4 million 52.5 million
2023-06-30 392.4 million 43.9 million
2023-03-31 263.2 million 39.6 million

COGT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -44.4 million 8.9 million
2023-09-30 -38.1 million 8.8 million
2023-06-30 -33.3 million 7.2 million
2023-03-31 -40.6 million 5.9 million

COGT Net Income

No data available :(

COGT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 265.7 million - 18.9 million
2023-09-30 312.8 million - 19.2 million
2023-06-30 350.9 million - 19.4 million
2023-03-31 220.3 million - 19.5 million

COGT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 86.7 million
2023-09-30 86.2 million
2023-06-30 74.8 million
2023-03-31 70.7 million

COGT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 315000 48.7 million 9.5 million -
2023-09-30 121000 50.1 million 9.5 million -
2023-06-30 1.3 million 38.9 million 8.2 million -
2023-03-31 1.1 million 36.0 million 7.2 million -

COGT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 794000
2023-09-30 - 855000
2023-06-30 - 1.2 million
2023-03-31 - 723000

COGT

Price: $7.53

52 week price:
3.67
13.50

Earnings Per Share: -2.42 USD

P/E Ratio: -2.44

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 528500

Ebitda: -29.7 million

Market Capitalization: 726.4 million

Links: